Autologous Platelet-Rich Fibrin in the Treatment of Refractory Macular Holes

  • Koytak A
  • Nuhoglu F
  • Bayraktar H
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose. To describe a novel method for the treatment of refractory macular holes. Methods. Two case reports on the use of autologous platelet rich fibrin (PRF), followed by sulfur hexafluoride gas tamponade to facilitate closure of refractory macular holes. Results. Macular holes were succesfully closed within a week in both cases. Best corrected Snellen visual acuities improved from counting fingers to 0.16 in the first case, and from 0.05 to 0.2 in the second case. No complication occurred during or after the procedures. Conclusion. The use of autologous PRF seems to be a safe and effective alternative method for the treatment of refractory macular holes. Further experience and studies are required to assess the value of autologous PRF in the management of challenging macular hole cases of different etiologies. To the best of our knowledge, this is the first use of autologous PRF in the treatment of macular holes.

Cite

CITATION STYLE

APA

Koytak, A., Nuhoglu, F., Bayraktar, H., Ercan, R., & Ozdemir, H. (2019). Autologous Platelet-Rich Fibrin in the Treatment of Refractory Macular Holes. Case Reports in Ophthalmological Medicine, 2019, 1–4. https://doi.org/10.1155/2019/6054215

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free